Saluda Medical is dedicated to improving the lives of people by providing personalised, responsive and efficient neuromodulation therapy.
Saluda Medical was established in 2013 with the goal of commercializing four years of research from NICTA, Australia’s information communications technology center of excellence.Our team is made up of world-class engineers, clinicians and seasoned professionals with experience in bringing medical technologies to life.Our company is founded on a strong foundation of science and we are dedicated to developing breakthrough
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 28, 2019 | Series Unknown | $75M | 1 | Boston Scientific | — | Detail |
Jun 27, 2019 | Debt Financing | — | 1 | Medtronic | — | Detail |
May 30, 2017 | Series D | $53M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Boston Scientific | Yes | Series Unknown |
Medtronic | Yes | Debt Financing |